Platinum compounds are a group of chemotherapeutic agents included in many pediatric and adult oncologic treatment protocols. The main platinum compounds are cisplatin, carboplatin, and oxaliplatin. Their use in clinical practice has greatly improved long-term survival of pediatric patients, but they also cause some toxic effects: ototoxicity, myelosuppression, nephrotoxicity, and neurotoxicity. Hearing damage is one of the main toxic effects of platinum compounds, and it derives from the degeneration of hair cells of the ear, which, not having self-renewal capacity, cannot reconstitute themselves. Hearing loss from platinum exposure is typically bilateral, sensorineural, and permanent, and it is caused by the same mechanisms with which platinum acts on neoplastic cells. According to available data from the literature, the optimal timing for the audiological test during and after treatment with platinum compounds is not well defined. Moreover, no substances capable of preventing the onset of hearing loss have been identified.

Romano, A., Capozza, M. A., Mastrangelo, S., Maurizi, P., Triarico, S., Rolesi, R., Attina', G., Fetoni, A. R., Ruggiero, A., Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer, <<CANCERS>>, 2020; 12 (5/1266): 1-15. [doi:DOI: 10.3390/cancers12051266] [http://hdl.handle.net/10807/155049]

Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer

Romano, Alberto;Capozza, Michele Antonio;Mastrangelo, Stefano;Maurizi, Palma;Rolesi, Rolando;Attina', Giorgio;Fetoni, Anna Rita;Ruggiero, Antonio
2020

Abstract

Platinum compounds are a group of chemotherapeutic agents included in many pediatric and adult oncologic treatment protocols. The main platinum compounds are cisplatin, carboplatin, and oxaliplatin. Their use in clinical practice has greatly improved long-term survival of pediatric patients, but they also cause some toxic effects: ototoxicity, myelosuppression, nephrotoxicity, and neurotoxicity. Hearing damage is one of the main toxic effects of platinum compounds, and it derives from the degeneration of hair cells of the ear, which, not having self-renewal capacity, cannot reconstitute themselves. Hearing loss from platinum exposure is typically bilateral, sensorineural, and permanent, and it is caused by the same mechanisms with which platinum acts on neoplastic cells. According to available data from the literature, the optimal timing for the audiological test during and after treatment with platinum compounds is not well defined. Moreover, no substances capable of preventing the onset of hearing loss have been identified.
Inglese
Romano, A., Capozza, M. A., Mastrangelo, S., Maurizi, P., Triarico, S., Rolesi, R., Attina', G., Fetoni, A. R., Ruggiero, A., Assessment and Management of Platinum-Related Ototoxicity in Children Treated for Cancer, <<CANCERS>>, 2020; 12 (5/1266): 1-15. [doi:DOI: 10.3390/cancers12051266] [http://hdl.handle.net/10807/155049]
File in questo prodotto:
File Dimensione Formato  
cancers-12-01266(1).pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 719.04 kB
Formato Adobe PDF
719.04 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/155049
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 11
social impact